{"id": "1358770195414851589", "creation": 1612791033.0, "user_id": "130912788", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "\ud83d\uddde\ufe0f @Ocugen &amp; @BharatBiotech have entered into a definitive agreement to co-develop, supply &amp; commercialize #COVAXIN, Bharat\u2019s #Covid19 #vaccine candidate, for the US market. The two-dose COVAXIN is currently under #EUA in India. PC: #Ocugen\n\u27a1\ufe0fhttps://t.co/BAgXwPA9c6\n\n#pharmanews https://t.co/MHZ98xxarA", "first_save": 1634559108.199414, "hashtags": ["#COVAXIN", "#COVID19", "#VACCINE", "#EUA", "#OCUGEN", "#PHARMANEWS"]}